 |
 |
 |  |
Home |
 |
 |
 |
Should we treat or not??? |
Performace Status |
Antiemetics |
Growth Factors |
Calculations |
Chemo Precautions |
TOXICITY CRITERIA |
Antidepressants |
Chemoprotection |
MESNA |
Dexrazoxane |
Radioprotectants |
Hypercalcemia of malignancy |
Mucositis |
Neutropenic Fever |
Palliative Care |
Radiation Oncology |
<<<<<<<<<>>>>>>>>> |
ALL |
AML |
Anal |
Bladder Cancer |
Brain Cancer |
Breast (risk category) |
Breast (adjuvant) |
Breast (metastatic) |
Breast (Xeloda) |
Breast (hormonal) |
Breast Cancer Genetics |
Carcinoid |
CLL |
CML |
COLON CANCER |
Endometrial |
Esophagous |
Gastric |
Gestational Trophoblastic Disease |
Germ Cell (Ovary) |
Hairy Cell Leukemia |
Head/Neck |
Head/Neck: ChemoRT abstracts |
Head/Neck: Larynx |
Head/Neck:Nasopharyngeal |
Hodgkins |
Islet Cell Tumors |
Kidney |
Liver |
LUNG, NSC |
Stage III Unresectable NSC Lung Cancer |
Lung, SC |
Lymphoma, Aggressive |
Lymphoma, AIDS |
Lymphoma, Burkitts |
Lymphoma, CNS |
Lymphoma, Cutaneous |
Lymphoma, Indolent |
Lymphoma, MALT |
Lymphoma, Mantle cell |
Lymphoma, Mediastinal B-Cell |
Lymphoma, Refractory NHL |
Melanoma |
Mesothelioma |
Multiple Myeloma |
MDS |
NHL |
Ovarian |
Pancreas |
Prostate |
Prostate (Hormonal) |
Rectal Cancer |
Sarcoma |
Sarcoma, Ewing's |
Sarcoma, Osteogenic |
Skeletal Metastasis |
Testicular Cancer |
Thymoma |
Thyroid Cancer |
Waldenstrom's |
Unknown Primary |
<<<<<<<<<>>>>>>>>> |
Molecular Genetics |
Oncogenes, the list! |
Immunoperoxidase stains |
Tumor Markers |
Bleomycin |
Cisplatin |
Etoposide |
Ifosfamide |
Methotrexate |
Temazolamide |
Mechanism of Action |
Dose Modifications (Renal) |
Dose Modifications (hepatic) |
MDR |
|
|  |
|
 |
Colon Cancer, Adjuvant Colon Cancer, metastatic
|
 |
***ADJUVANT COLON CANCER: 5FU + Leucovorin ---- Low-dose 5FU 425 mg/m2/d IV bolus DAYS 1-5 Leucovorin 20 mg/m2 IV bolus DAYS 1-5 immediately before 5FU Repeat cycle at 4 weeks, 8 weeks, then Q5weeks JCO 7:1407-1418, 1989 --------------------------------------------------------------------------- Adjuvant High Dose Leucovorin + 5FU Leucovorin 500 mg/m2 IV over 2 hours Q week X 6 weeks 5 FU 500 mg/m2 IV over 1 hour after the start of leucovorin Qweek X 6 weeks Repeat Q8weeks X 6 cycles Proc Am Soc Clin Oncol 15:205, 1996 --------------------------------------------------------------------------- Advanced Colorectal CA: Bimonthly high-dose leucovorin & 5FU bolus plus CI (LV5FU2) LV 200 mg/m2 as a 2-hour infusion followed by bolus 5-FU 400 mg/m2 and 22-hour infusion 5FU 600 mg/m2 for 2 consecutive days every 2 weeks REF: JCO 15:808, 1997 LV5FU2 was superior to 5FU/LV monthly 5-day regimen in terms of RR, PFS, toxicity but not OS RR: 32.6% vs 14.5% P = .0004 PFS: 27.6 wks vs 22 wks P = .0012 Grade 3-4: 11.1% vs 22.9% P = .0004 OS: 56.8 weeks vs 62 weeks P = .067 ___________________________________________ ***METASTATIC COLON CANCER: 5FU+Leucovorin+Irinotecan Qweek X 4 (of 6 weeks) IRINOTECAN 125 mg/m2 LEUCOVORIN 20 mg/m2 bolus 5FU 500 mg/m2 bolus Proc Am Soc Clin Oncol 18:2333a, 1999 --------------------------------------------------------------------------- IRINOTECAN Single agent: IRINOTECAN 350 mg/m2 Q3weeks ___________________________________________
|
 |
|
|  |
TOXICITIES: IRIONOTECAN: Diarrhea- use lopramide 4 mg loading dose followed by 2 mg Q2hours until diarrhea stops for at least 12 hours |
 |
 |
. |
|
|